Note: Ingredients listed on restricted chemical lists
EC/CAS
68359-37-5
Name of the chemical
Cyfluthrin (ISO); α-Cyan-4-fluor-3-phenoxybenzyl-3-(2,2-dichlorvinyl)-2,2-dimethylcyclopropancarboxylat (2022/692)
Concentration
N/A
General Information
Revision date
2000-06-27
Product name
BAYER ADVANCED GARDEN Rose & Flower Insect Killer Concentrate
Product Synonyms
Imidacloprid, Cyfluthrin
Chemical name
1-((6-Chloro-3-pyridinyl)methyl)-N-nitro-2-imidazolidini
1.2.1 Relevant identified uses
Consumer Insecticide -------------------------------------------------------------------------------
Emergency telephone
(800) 414-0244
Icons in SDS
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW * CAUTION! Color Tan; Form Liquid; Opaque; Harmful if * * inhaled or ingested; Causes eye irritation. * *****************************************************************
Principle Routes of Exposure
Inhalation; Skin Contact; Eye Contact HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE: ACUTE EFFECTS OF EXPOSURE.....: Exposure during the labeled use of this product is expected to be minimal. Consumers should refer to the packaging label for proper handling procedures. Sufficient exposures to cyfluthrin, an active ingredient in this product, may cause eye or skin irritation characterized by redness or itching. In addition, sufficient exposure to cyfluthrin may produce paraesthesia, a tingling or burning sensation on the surface of the skin. This is a frequently reported symptom associated with sufficient dermal exposure to alpha-cyano (or Type II) synthetic pyrethroids and normally subsides without treatment within 24 hours. The onset of these symptoms usually occurs 2-12 hours after exposure. Mucous membrane irritation involving the nose, throat and upper respiratory tract may occur from inhalation of aerosols containing cyfluthrin. Based on EPA Toxicity Category criteria, this product is essentially non-toxic by the oral and dermal routes of exposure.
Potential chronic health
OF EXPOSURE... Based on animal studies, no adverse effects are expected from chronic exposure to this product. CARCINOGENICITY...............: This product is not listed by NTP, IARC or regulated as a carcinogen by OSHA. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE......: No specific medical conditions are known which may be aggravated by exposure to the active ingredients in this product. As with all materials which can cause upper respiratory tract irritation, (Continued) --------------------------------------- persons with a history of asthma, emphysema, or hyperreactive airway disease may be more susceptible to a response at low concentration. -------------------------------------------------------------------------------
